- Home
- UBX vs AIHS Comparison
UBX vs AIHS Comparison
Compare UBX & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- AIHS
- Stock Information
- Founded
- UBX 2009
- AIHS 2014
- Country
- UBX United States
- AIHS China
- Employees
- UBX N/A
- AIHS N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- AIHS Finance: Consumer Services
- Sector
- UBX Health Care
- AIHS Finance
- Exchange
- UBX Nasdaq
- AIHS Nasdaq
- Market Cap
- UBX 13.9M
- AIHS 11.9M
- IPO Year
- UBX 2018
- AIHS 2018
- Fundamental
- Price
- UBX $0.78
- AIHS $0.32
- Analyst Decision
- UBX Strong Buy
- AIHS
- Analyst Count
- UBX 3
- AIHS 0
- Target Price
- UBX $4.67
- AIHS N/A
- AVG Volume (30 Days)
- UBX 609.1K
- AIHS 4.2M
- Earning Date
- UBX 08-05-2025
- AIHS 08-13-2025
- Dividend Yield
- UBX N/A
- AIHS N/A
- EPS Growth
- UBX N/A
- AIHS N/A
- EPS
- UBX N/A
- AIHS N/A
- Revenue
- UBX N/A
- AIHS $5,878,700.00
- Revenue This Year
- UBX N/A
- AIHS N/A
- Revenue Next Year
- UBX N/A
- AIHS N/A
- P/E Ratio
- UBX N/A
- AIHS N/A
- Revenue Growth
- UBX N/A
- AIHS 12.21
- 52 Week Low
- UBX $0.36
- AIHS $0.26
- 52 Week High
- UBX $3.10
- AIHS $1.70
- Technical
- Relative Strength Index (RSI)
- UBX 48.12
- AIHS 30.64
- Support Level
- UBX $0.67
- AIHS $0.29
- Resistance Level
- UBX $0.83
- AIHS $0.35
- Average True Range (ATR)
- UBX 0.09
- AIHS 0.16
- MACD
- UBX 0.01
- AIHS -0.06
- Stochastic Oscillator
- UBX 24.67
- AIHS 3.70
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About AIHS Senmiao Technology Limited
Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.